Ling Zhao
- Aging top 0.5%
- Molecular Biology top 2%
- Retinal Development and Disorders 8
- Extracellular vesicles in disease 7
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Ophthalmology top 2%
- Retinal Diseases and Treatments 11
- Glaucoma and retinal disorders 8
-
- Liver Disease Diagnosis and Treatment 6
-
- EEG and Brain-Computer Interfaces 5
-
- Adipose Tissue and Metabolism 4
- Co-authors
- Kang ZhangGuy HughesMarina BibikovaJustin GuinneyLi ZhangTrey IdekerBrandy KlotzleGregory Hannum
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Ling Zhao
105 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Aging 474
- Molecular Biology 3.9k
- Cancer Research 608
- Pediatrics, Perinatology and Child Health 681
- Ophthalmology 297
Countries citing papers authored by Ling Zhao
This map shows the geographic impact of Ling Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhao more than expected).
Fields of papers citing papers by Ling Zhao
This network shows the impact of papers produced by Ling Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhao. The network helps show where Ling Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 28 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 76 | |
| 11 | 2022 | 60 | |
| 12 | 2020 | 33 | |
| 13 | 2018 | 41 | |
| 14 | 2016 | 45 | |
| 15 | 2013 | 10 | |
| 16 | 2013 | 28 | |
| 17 | 2013 | 7 | |
| 18 | A Novel Compound Heterozygous Mutation in the BEST1 Gene Causes Autosomal Recessive Best Vitelliform Macular Dystrophy | 2012 | 1 |
| 19 | 2010 | 3 | |
| 20 | TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formationbreakdown → | 2009 | 906 |
About Ling Zhao
Ling Zhao is a scholar working on Ophthalmology, Aging and Research and Theory, having authored 116 papers that have together received 6.2k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Glaucoma and retinal disorders (8 papers), MicroRNA in disease regulation (8 papers), Retinal Development and Disorders (8 papers), Extracellular vesicles in disease (7 papers), Liver Disease Diagnosis and Treatment (6 papers), EEG and Brain-Computer Interfaces (5 papers) and Adipose Tissue and Metabolism (4 papers). The work is most often cited by research in Aging (474 citations), Molecular Biology (3.9k citations) and Cancer Research (608 citations). Ling Zhao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Kang Zhang, Guy Hughes, Marina Bibikova, Justin Guinney, Li Zhang, Trey Ideker, Brandy Klotzle, Gregory Hannum, Stephen Friend and Indika Rajapakse. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.